Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

NEO/ZLLY stock hub

NEO/ZLLY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NEO/ZLLYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2T

Cboe Canada

Market data

Live price

Current market quote for this ticker.

Current price

NEO/ZLLY

In the news

Latest news · NEO/ZLLY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.4

P25 11P50 15.6P75 25.4

Trailing P/E32.8

P25 7.4P50 15.6P75 34.3

ROE107.5

P25 -121.5P50 -40.9P75 0.5

ROIC41.9

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NEO/ZLLY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

200

Groups with data

Currency

USD

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CA
Employees	50,000
Employees Change	3,000%
Employees Change Percent	6.38
Enterprise value	CAD 1.2T
Exchange	Cboe Canada
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	CAD 1.2T
Price	CAD 10.27
Price currency	CAD
Rev Per Employee	2,016,989.78x
Sector	Healthcare
Sic	2834
Symbol	neo/ZLLY
Website	https://www.lilly.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.05%
EV Earnings	34.27x
EV/EBIT	25.85x
EV/EBITDA	24.25x
EV/FCF	73.28x
EV/Sales	12.23x
FCF yield	1.43%
Forward P/E	25.41x
P/B ratio	26.59x
P/E ratio	32.81x
P/S ratio	11.48x
PE Ratio10 Y	52.61x
PE Ratio3 Y	73.78x
PE Ratio5 Y	62.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	47.3%
EBITDA Margin	50.13%
FCF margin	16.36%
Gross margin	82.83%
Gross Profit	CAD 83.5B
Gross Profit Growth	49.48%
Gross Profit Growth Q	54.44%
Gross Profit Growth3 Y	40.65%
Gross Profit Growth5 Y	25.35%
Net Income	CAD 35.3B
Net Income Growth	127.6%
Net Income Growth Q	168.07%
Net Income Growth3 Y	64.42%
Net Income Growth5 Y	32.92%
Pretax Margin	43.08%
Profit Margin	34.99%
Profit Per Employee	CAD 705,663
ROA	20.74
Roa5y	13.51
ROCE	42.75
ROE	107.5
Roe5y	74.21
ROIC	41.92
Roic5y	35.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	129.1
EPS Growth Q	169.9
EPS Growth3 Y	64.8
EPS Growth5 Y	33.34
FCF Growth	216.44%
FCF Growth Q	1,827.56%
FCF Growth3 Y	36.63%
FCF Growth5 Y	13.11%
OCF Growth	119.79%
OCF Growth Q	220.11%
OCF Growth10 Y	21.88%
OCF Growth3 Y	44.46%
OCF Growth5 Y	21.25%
Revenue Growth	47.44x
Revenue Growth Q	55.54x
Revenue Growth3 Y	37.67x
Revenue Growth5 Y	23.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.7
Assets	CAD 162.7B
Cash	CAD 7.4B
Current Assets	CAD 75B
Current Liabilities	CAD 50.1B
Debt	CAD 60.5B
Debt EBITDA	CAD 1.19
Debt Equity	CAD 1.39
Debt FCF	CAD 3.67
Equity	CAD 43.5B
Interest Coverage	388.3
Liabilities	CAD 119.2B
Long Term Assets	CAD 87.8B
Long Term Liabilities	CAD 69.1B
Net Cash	CAD -52.5B
Net Cash By Market Cap	CAD -4.54
Net Debt EBITDA	CAD 1.04
Net Debt Equity	CAD 1.21
Net Debt FCF	CAD 3.18
Tangible Book Value	CAD 24.7B
Tangible Book Value Per Share	CAD 27.64
WACC	6.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.5
Inventory Turnover	1.04
Net Working Capital	CAD 23.6B
Quick ratio	0.72
Working Capital	CAD 25.4B
Working Capital Turnover	CAD 6.86

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.57%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CAD 0.02
Dividend Years	1
Dividend Yield	0.18%
Ex Div Date	2026-02-13
Last Dividend	CAD 0.02
Payout Ratio	22.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	12.05
All Time High Change	-14.36%
All Time High Date	2026-01-08
All Time Low	9.09
All Time Low Change	13.53%
All Time Low Date	2026-04-29
ATR	0.27
Beta	0.5
Ch YTD	-11.34
High	10.27
High52	12.05
High52 Date	2026-01-08
High52ch	-14.77%
Low	10.27
Low52	9.09
Low52 Date	2026-04-29
Low52ch	12.98%
RSI	50.83
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	-0.96x
Sortino ratio	-1.24
Total Return	0.75%
Tr YTD	-11.2
Tr1m	2.69%
Tr1w	13.53%
Tr3m	-7.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 47.7B
Operating Income Growth	74.29
Operating Income Growth Q	84.42
Operating Income Growth3 Y	64.3
Operating Income Growth5 Y	36.9
Operating margin	47.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	889,347,313%
Net Borrowing	6,102,511,200
Shares Insiders	0.17%
Shares Institutions	90.01%
Shares Qo Q	-0.23%
Shares Yo Y	-0.57%
Short Ratio	2.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 15.6B
Average Volume	363.8x
Bv Per Share	48.74
CAPEX	CAD -12.1B
Ch1m	2.69
Ch1w	13.53
Ch3m	-7.36
Change	0%
Change From Open	0
Depreciation Amortization	2,792,883,150
Dollar Volume	1,160.5
Earnings Date	2026-04-30
EBIT	CAD 47.7B
EBITDA	CAD 50.6B
EPS	CAD 39.3
F Score	6
FCF	CAD 16.5B
FCF EV Yield	1.36x
Financing CF	-9,858,959,180
Fiscal Year End	December
Founded	1,876
Goodwill	8,380,016,500
Graham Number	1.64929
Graham Upside	-83.94
Income Tax	CAD 8.2B
Investing CF	-16,101,245,100
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	CAD 7.82
Lynch Upside	-23.81
Ma20	9.89
Ma20ch	4.32%
Net CF	3,055,537,540
Open	10.27
P FCF Ratio	70.16
P OCF Ratio	40.5
Ppne	36,281,507,000
Price Date	2026-05-04
Price EBITDA	CAD 22.9
Ptbv Ratio	46.88
Relative Volume	0.31x
Revenue	100,849,489,140x
SBC By Revenue	0.88x
Share Based Comp	883,579,380
Tax By Revenue	8.09x
Tax Rate	18.79%
Volume	113
Z Score	7.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NEO/ZLLY dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$0.02 annual per share

Payout ratio

+22.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.8%

Next ex-dividend date: 2026-02-13

Ownership

Who owns NEO/ZLLY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.0%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NEO/ZLLY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.8

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

0.50

Less volatile than the market

Sharpe ratio

-0.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NEO/ZLLY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current neo/ZLLY stock rating?

neo/ZLLY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full neo/ZLLY analysis?

The full report lives at /stocks/neo/ZLLY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for neo/ZLLY?

The latest report frames neo/ZLLY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the neo/ZLLY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.